Cargando…

Administration of a selective retinoic acid receptor-γ agonist improves neuromuscular strength in a rodent model of volumetric muscle loss

PURPOSE: Volumetric muscle loss is a uniquely challenging pathology that results in irrecoverable functional deficits. Furthermore, a breakthrough drug or bioactive factor has yet to be established that adequately improves repair of these severe skeletal muscle injuries. This study sought to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitely, Michael E., Collins, Patrick B., Iwamoto, Masahiro, Wenke, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360252/ https://www.ncbi.nlm.nih.gov/pubmed/34383202 http://dx.doi.org/10.1186/s40634-021-00378-3

Ejemplares similares

Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor γ Agonists
por: Shimono, Kengo, et al.
Publicado: (2011)

Tacrolimus as an adjunct to autologous minced muscle grafts for the repair of a volumetric muscle loss injury
por: Corona, Benjamin T., et al.
Publicado: (2017)

Synthesis of A-9758, an Inverse Agonist of Retinoic Acid-Related Orphan Receptor γt
por: Marvin, Christopher C., et al.
Publicado: (2022)

Early rehabilitation for volumetric muscle loss injury augments endogenous regenerative aspects of muscle strength and oxidative capacity
por: Greising, Sarah M., et al.
Publicado: (2018)

Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists
por: Meijer, Femke A., et al.
Publicado: (2019)

Effect of Specific Retinoic Acid Receptor Agonists on Noise-Induced Hearing Loss
por: Kwak, Sang Hyun, et al.
Publicado: (2019)

Neuromuscular Correlates of the Contralateral Stretch-induced Strength Loss
por: CORATELLA, GIUSEPPE, et al.
Publicado: (2021)

Unwavering Pathobiology of Volumetric Muscle Loss Injury
por: Greising, Sarah M., et al.
Publicado: (2017)

Understanding the Action of RARγ Agonists on Human Osteochondroma Explants
por: Garcia, Sonia A., et al.
Publicado: (2020)

Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
por: Liu, Yang, et al.
Publicado: (2015)

An Autologous Muscle Tissue Expansion Approach for the Treatment of Volumetric Muscle Loss
por: Ward, Catherine L., et al.
Publicado: (2015)

Human muscle in gene edited pigs for treatment of volumetric muscle loss
por: Greising, Sarah M., et al.
Publicado: (2022)

Discovery of Retinoic Acid-Related Orphan Receptor γt Inverse Agonists via Docking and Negative Image-Based Screening
por: Rauhamäki, Sanna, et al.
Publicado: (2018)

The Neuromuscular Fatigue-Induced Loss of Muscle Force Control
por: Pethick, Jamie, et al.
Publicado: (2022)

Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss
por: Kiran, Sonia, et al.
Publicado: (2021)

Retrospective characterization of a rat model of volumetric muscle loss
por: Dolan, Connor P., et al.
Publicado: (2022)

Physical rehabilitation improves muscle function following volumetric muscle loss injury
por: Aurora, Amit, et al.
Publicado: (2014)

Neuromuscular Compression Garments: Effects on Neuromuscular Strength and Recovery
por: Bottaro, Martim, et al.
Publicado: (2011)

Skeletal Muscle Tissue Engineering: Biomaterials-Based Strategies for the Treatment of Volumetric Muscle Loss
por: Carnes, Meagan E., et al.
Publicado: (2020)

Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss
por: Clark, Andrew, et al.
Publicado: (2022)

Systemic Administration of the TRPV3 Ion Channel Agonist Carvacrol Induces Hypothermia in Conscious Rodents
por: Feketa, Viktor V., et al.
Publicado: (2015)

Pre-Clinical Cell Therapeutic Approaches for Repair of Volumetric Muscle Loss
por: Shayan, Mahdis, et al.
Publicado: (2020)

The impact of bilateral injuries on the pathophysiology and functional outcomes of volumetric muscle loss
por: Dolan, Connor P., et al.
Publicado: (2022)

Transcriptome profiling of a synergistic volumetric muscle loss repair strategy
por: Roberts, Kevin, et al.
Publicado: (2023)

In silico discovery of novel Retinoic Acid Receptor agonist structures
por: Schapira, Matthieu, et al.
Publicado: (2001)

The Immediate Effect of Neuromuscular Joint Facilitation (NJF) Treatment on Hip Muscle Strength
por: Wang, Hongdan, et al.
Publicado: (2013)

Neuromuscular Electrical Stimulation and Strength Recovery of Postnatal Diastasis Recti Abdominis Muscles
por: Kamel, Dalia M., et al.
Publicado: (2017)

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
por: Wei, Cheng-Hsin, et al.
Publicado: (2023)

Robust inflammatory and fibrotic signaling following volumetric muscle loss: a barrier to muscle regeneration
por: Larouche, Jacqueline, et al.
Publicado: (2018)

Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model
por: Ma, Jinjin, et al.
Publicado: (2017)

In situ forming biomaterials as muscle void fillers for the provisional treatment of volumetric muscle loss injuries
por: Clark, Andrew, et al.
Publicado: (2023)

Multiscale analysis of a regenerative therapy for treatment of volumetric muscle loss injury
por: Aguilar, Carlos A., et al.
Publicado: (2018)

Biofabricating murine and human myo‐substitutes for rapid volumetric muscle loss restoration
por: Costantini, Marco, et al.
Publicado: (2021)

Spatiotemporal mapping of immune and stem cell dysregulation after volumetric muscle loss
por: Larouche, Jacqueline A., et al.
Publicado: (2023)

Relative contribution of neuromuscular activation, muscle size, and muscle quality to maximum strength output of the thigh muscles in young individuals
por: Yoshiko, Akito, et al.
Publicado: (2023)

Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2011)

Reliability of Muscle Strength and Muscle Power Assessments Using Isokinetic Dynamometry in Neuromuscular Diseases: A Systematic Review
por: van der Woude, Danny R, et al.
Publicado: (2022)

Selective Retinoic Acid Receptor γ Antagonist 7C is a Potent Enhancer of BMP-Induced Ectopic Endochondral Bone Formation
por: Tateiwa, Daisuke, et al.
Publicado: (2022)

Agonist-induced myopathy at the neuromuscular junction is mediated by calcium
Publicado: (1979)

Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss
por: Dirks, Marlou L.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k1u9ucoqspabbgf72deujk1uqq